Position in LYEL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$110,222
+$68,157 QoQ
Shares Held
7,845
+274.1% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#58
of 87 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in LYEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BNP PARIBAS ARBITRAGE, SA holds $3,331,911,027 across 414 Biotechnology names. LYEL ranks #223 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
4,377,120 | $306,529,713 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
399,847 | $249,320,598 | |
| 3 | ARGX |
Argenx SE
|
157,958 | $146,548,693 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
262,258 | $130,271,416 | |
| 5 | BNTX |
BioNTech SE
|
1,319,517 | $122,781,056 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
552,710 | $103,511,528 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
1,079,015 | $102,689,857 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,155,442 | $86,057,320 |
All Filings in LYEL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $110,222 | 7,845 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $42,065 | 2,097 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $97,572 | 3,170 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $5,765 | 355 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,120 | 353 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $89,444 | 166,253 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $162,348 | 253,669 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||